Ignite Creation Date:
2025-12-24 @ 2:20 PM
Ignite Modification Date:
2025-12-25 @ 10:55 PM
Study NCT ID:
NCT07042295
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-12-24
First Post:
2025-06-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-03-22
Start Date Type:
ESTIMATED
Primary Completion Date:
2029-02-28
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-02-28
Completion Date Type:
ESTIMATED
First Submit Date:
2025-06-27
First Submit QC Date:
None
Study First Post Date:
2025-06-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-23
Last Update Post Date:
2025-12-24
Last Update Post Date Type:
ACTUAL